These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The use of topical phenytoin as an adjunct to immobilization in the treatment of trophic leprosy ulcers. Menezes J; Rajendran A; Jacob AJ; Vaz M Southeast Asian J Trop Med Public Health; 1993 Jun; 24(2):340-2. PubMed ID: 8266239 [TBL] [Abstract][Full Text] [Related]
27. Letter: Amitriptyline and imipramine poisoning in children. Br Med J; 1974 Mar; 1(5907):575. PubMed ID: 4131645 [No Abstract] [Full Text] [Related]
28. [Suppression of arrhythmias due to glycoside intolerance using diphenylhydantoin]. Kaufmann G; Haser K Verh Dtsch Ges Kreislaufforsch; 1969; 35():236-40. PubMed ID: 4192081 [No Abstract] [Full Text] [Related]
29. Bioavailability of phenytoin sodium capsules available in Thailand. Part II: In vivo study. Suthisisang C; Payakachat N; Chulavatnatol S; Towanabut S J Med Assoc Thai; 1998 Jan; 81(1):64-70. PubMed ID: 9470324 [TBL] [Abstract][Full Text] [Related]
30. [Oral therapy of cardiac arrhythmia using Neo-Gilurytmal (N-n-propyl-ajmalinium-hydrogentartrate)]. Mathey D; Bleifeld W; Effert S Med Klin; 1973 May; 68(18):598-601. PubMed ID: 4123381 [No Abstract] [Full Text] [Related]
32. [Ventricular parasystole: successful treatment with diphenylhydantoin]. Zanini S; Rossi R G Ital Cardiol; 1972; 2(4):575-8. PubMed ID: 4115174 [No Abstract] [Full Text] [Related]
33. Bioavailability of phenytoin: comparison between three preparations. Kitzes R; Ackerman Z; Levy M; Frumerman I; Shved A; Garty M Isr J Med Sci; 1985 Apr; 21(4):323-6. PubMed ID: 3997494 [TBL] [Abstract][Full Text] [Related]
34. [Potassium and disorders of cardiac rhythm in clinical research]. Ballarino M; Rumolo R Atti Soc Ital Cardiol; 1967; 2():148-9. PubMed ID: 4173069 [No Abstract] [Full Text] [Related]
35. Pharmacokinetics of three formulations of diphenylhydantoin in the dog. Overduin LM; van Gogh H; Mol JA; van Nes JJ Res Vet Sci; 1989 Mar; 46(2):271-3. PubMed ID: 2704892 [TBL] [Abstract][Full Text] [Related]
36. Effect of piperine on the steady-state pharmacokinetics of phenytoin in patients with epilepsy. Pattanaik S; Hota D; Prabhakar S; Kharbanda P; Pandhi P Phytother Res; 2006 Aug; 20(8):683-6. PubMed ID: 16767797 [TBL] [Abstract][Full Text] [Related]
37. The PVC, Part II: Treatment. Fortuin NJ Md State Med J; 1974 Dec; 23(12):32-3. PubMed ID: 4139392 [No Abstract] [Full Text] [Related]
38. [Bioavailability of two commercial phenytoin preparations (author's transl)]. Yahaba Y; Obata N; Hidano F; Hori H; Unno K Seishin Shinkeigaku Zasshi; 1981; 83(9):582-96. PubMed ID: 7330117 [No Abstract] [Full Text] [Related]
39. Formulation and in vitro and in vivo characterization of a phenytoin self-emulsifying drug delivery system (SEDDS). Atef E; Belmonte AA Eur J Pharm Sci; 2008 Nov; 35(4):257-63. PubMed ID: 18706499 [TBL] [Abstract][Full Text] [Related]
40. [Evaluation of the relative biological availability of amiodarone Polfa preparation after extravascular administration of a single dose]. Paczkowski D; Sadowski Z; Koliński P; Filipek M; Podleśny J Kardiol Pol; 1989; 32(6):326-33. PubMed ID: 2632911 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]